BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11980984)

  • 1. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer.
    Redding SW; Kirkpatrick WR; Coco BJ; Sadkowski L; Fothergill AW; Rinaldi MG; Eng TY; Patterson TF
    J Clin Microbiol; 2002 May; 40(5):1879-81. PubMed ID: 11980984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.
    Redding SW; Dahiya MC; Kirkpatrick WR; Coco BJ; Patterson TF; Fothergill AW; Rinaldi MG; Thomas CR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jan; 97(1):47-52. PubMed ID: 14716255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
    Redding SW; Bailey CW; Lopez-Ribot JL; Kirkpatrick WR; Fothergill AW; Rinaldi MG; Patterson TF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):659-62. PubMed ID: 11402278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.
    Redding SW; Kirkpatrick WR; Dib O; Fothergill AW; Rinaldi MG; Patterson TF
    Spec Care Dentist; 2000; 20(5):178-81. PubMed ID: 11203894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
    Bussaratid V; Tansupasawasdikul S; Simpson A; Pitisuttithum P; Phonrat B; Howe P; White NJ
    J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer.
    Dahiya MC; Redding SW; Dahiya RS; Eng TY; Kirkpatrick WR; Coco BJ; Sadkowski LC; Fothergill AW; Waite A; Rinaldi MG; Patterson TF; Thomas CR
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):79-83. PubMed ID: 12909218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
    Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation.
    Redding SW; Kirkpatrick WR; Saville S; Coco BJ; White W; Fothergill A; Rinaldi M; Eng T; Patterson TF; Lopez-Ribot J
    J Clin Microbiol; 2003 Feb; 41(2):619-22. PubMed ID: 12574256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.
    Redding SW; Zellars RC; Kirkpatrick WR; McAtee RK; Caceres MA; Fothergill AW; Lopez-Ribot JL; Bailey CW; Rinaldi MG; Patterson TF
    J Clin Microbiol; 1999 Dec; 37(12):3896-900. PubMed ID: 10565903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011.
    Bensadoun RJ; Patton LL; Lalla RV; Epstein JB
    Support Care Cancer; 2011 Jun; 19(6):737-44. PubMed ID: 21479787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.
    Arikan S; Akova M; Hayran M; Ozdemir O; Erman M; Gür D; Unal S
    Clin Infect Dis; 1998 Apr; 26(4):903-8. PubMed ID: 9564473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors].
    Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
    Mycoses; 1997; 40 Suppl 1():53-5. PubMed ID: 9417514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours.
    Finlay PM; Richardson MD; Robertson AG
    Br J Oral Maxillofac Surg; 1996 Feb; 34(1):23-5. PubMed ID: 8645677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
    Revankar SG; Dib OP; Kirkpatrick WR; McAtee RK; Fothergill AW; Rinaldi MG; Redding SW; Patterson TF
    Clin Infect Dis; 1998 Apr; 26(4):960-3. PubMed ID: 9564483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
    Tan GL; Peterson EM
    J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients.
    Schwab U; Chernomas F; Larcom L; Weems J
    Diagn Microbiol Infect Dis; 1997 Sep; 29(1):11-7. PubMed ID: 9350410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers.
    Koc M; Aktas E
    Jpn J Clin Oncol; 2003 Feb; 33(2):57-60. PubMed ID: 12629054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
    Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.